PenMetabolic · Mitochondrial
MOTS-C 25 mg
A mitochondrial-derived peptide studied for metabolic homeostasis and exercise adaptation.
View 25 mg
MOTS-C PENMetabolic · Mitochondrial
MOTS-C 15 mg
Strength 15 mg / 3 mLPurity HPLCForm Pre-filled penCOA Per batch
A mitochondrial-derived peptide (MDP) studied for its role in metabolic homeostasis, insulin sensitivity and exercise-related adaptation, here as a ready-to-use 15 mg pen.
Researched directions
- Metabolic homeostasis & insulin-sensitivity research
- AMPK-pathway activation endpoints
- Exercise-adaptation and endurance models
- Mitochondrial-stress response studies
Available to verified researchers. Pricing and the batch Certificate of Analysis are shared on request.
About MOTS-C
MOTS-c is a mitochondrial-derived peptide studied for regulating metabolic homeostasis via AMPK signalling, with research interest across insulin sensitivity, exercise adaptation and metabolic-ageing models. This 15 mg pen supports repeat-dose study designs.
Features
MOTS-C is supplied in the NADOVA LABS GoQuick pre-filled pen — a graduated, ready-to-use subcutaneous delivery format that removes reconstitution and simplifies repeat-dose study designs. Each pen is prepared from HPLC-verified material, dose-marked on the barrel, and shipped refrigerated with a Certificate of Analysis available per batch.
Handling & compliance
This pre-filled pen is intended strictly for in-vitro and laboratory research. It is not a drug, supplement, or medical device, and is not for human use. Store refrigerated at 2–8 °C, protect from light, and follow accepted laboratory practice; exact specifications for your lot are listed on its Certificate of Analysis.
Related compounds
Back to catalogue Pen
PenMetabolic · NNMT inhibitor
5-Amino-1MQ 25 mg
A selective NNMT inhibitor studied for fat-mass reduction and NAD⁺ research.
View 25 mg
Every batch, documented.
Request a researcher account to view the Certificate of Analysis for this lot and place an order with the lab.